| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |